Replies to post #229244 on Biotech Values

[dewophile]

I believe the same goes for vaccine production.

Vaccine margins are probably lower for the flu where you have to gear up for new strains every year, but all in all vaccines are a great business to be in bc margins are high and there is no patent cliff and there is a higher barrier to entry compared to traditional drugs. There is of course commercial risk e.g. if someone comes along w a better version of vaccine

[jbog]

I believe the same goes for vaccine production.

You might want to look at Prevnar or Shingrix.

[Biowatch]

Vaccine manufactureres face lawsuits if anyone suffers a problem after getting vaccinated, regardless of whether the vaccine caused the problem.

This makes it a HIGH RISK as well as low reward field to pursue, no matter how much it could benefit public health.